Stanford researchers have developed the Evo 2 AI model to generate phages capable of targeting E. coli. The model synthesized nearly 300 phages, with 16 demonstrating strong antibacterial activity in laboratory tests. This work highlights the potential of AI in designing entire viral genomes, offering a new approach to combat bacterial resistance. Evo 2 is available as open-source software, allowing other researchers to explore its capabilities in genome design. The project could lead to new treatments for resistant bacteria and open new avenues in synthetic biology.
Read originalTopicAI Designed VirusesCooling
Earlier coverage that leads up to this article, and what followed. Lines connect each piece to the closest one after it, converging here.
MIT News AI · April 17, 2026 · Background
The Rundown AI · May 28, 2026 · Background
OpenAI · June 30, 2026 · Background
WIRED AI · July 12, 2026 · Background
The Rundown AI · August 20, 2026 · Background
MIT News AI · August 27, 2026 · Background
The Verge AI · September 8, 2026 · Background
OpenAI · September 10, 2026 · Background
Wes Roth · September 24, 2026 · Background
AI Designs Novel Viruses to Combat Drug Resistance
5 developments